Branching Tree BV Revenue
Pharmaceutical Manufacturing • • 1-10 Employees
$
Branching Tree BV revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Branching Tree BV
Ray Huegel
president
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 3254 |
| SIC | 873 |
| Keywords | Oncology, Biodegradable Polymers, Injectable Drug Delivery Depots, Generics And Biologicals |
| Founded | 2007 |
| Employees | 1-10 |
About Branching Tree BV
Branching Tree BV (Maastricht,NL) is the original inventor and developer of the InGell technology: injectable, biodegradable drug delivery depots for localized and for slow release of generic and novel drugs. The company also founded InGell Technologies Holding BV and InGell Labs BV in Groningen. In 2017 Branching Tree will start up a new company focused on drug delivery for Oncology applications.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Vice President
Funding Data
Branching Tree BV has never raised funding before.
Sweden
Belgium
United KingdomFrequently asked questions
Branching Tree BV is located in XX.
Branching Tree BV generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
Branching Tree BV has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Branching Tree BV was founded in 2007, making it 19 years old. The company has established itself as a significant player in its industry over this time.
Branching Tree BV has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
